Oxidation-induced structural changes of Ceruloplasmin Foster NGR Motif Deamidation That Promotes Integrin binding and signaling

Journal of Biological Chemistry

Volumn 289, Issue 6, 2014, Pages 3736-3748

  Barbariga, Marco ^a   Curnis, Flavio ^b   Spitaleri, Andrea ^c,d   Andolfo, Annapaola ^e   Zucchelli, Chiara ^c,d   Lazzaro, Massimo ^a   Magnani, Giuseppe ^a   Musco, Giovanna ^c,d   Corti, Angelo ^b   Alessio, Massimo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b Tumor Biology and Vascular Targeting   (Italy)

^c DULBECCO TELETHON INSTITUTE   (Italy)

^d Biomolecular NMR Spectroscopy   (Italy)

^e Proteomics Service   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; CERULOPLASMIN; INTEGRINS; ISONGR MOTIF; NGR MOTIF; OXIDATIVE STRESS; PROTEIN DEAMIDATION; PROTEIN MISFOLDING; STRUCTURAL BIOLOGY;

ALZHEIMER DISEASE; AMINO ACID MOTIFS; CELL ADHESION; CELL LINE, TUMOR; CERULOPLASMIN; HUMANS; INTEGRINS; OXIDATION-REDUCTION; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 84893667859     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.520981     Document Type: Article

References (47)

1. Weintraub, S. J., and Deverman, B. E. (2007) Chronoregulation by asparagine deamidation. Sci. STKE 2007, re7
2. Robinson, N. E., Robinson, Z. W., Robinson, B. R., Robinson, A. L., Robinson, J. A., Robinson, M. L., and Robinson, A. B. (2004) Structure-dependent nonenzymatic deamidation of glutaminyl and asparaginyl pentapeptides. J. Pept. Res. 63, 426-436
3. Robinson, N. E., and Robinson, A. B. (2001) Molecular clocks. Proc. Natl. Acad. Sci. U.S.A. 98, 944-949
4. Ingrosso, D., D'Angelo, S., di Carlo, E., Perna, A. F., Zappia, V., and Galletti, P. (2000) Increased methyl esterification of altered aspartyl residues in erythrocyte membrane proteins in response to oxidative stress. Eur. J. Biochem. 267, 4397-4405
5. Ingrosso, D., Cimmino, A., D'Angelo, S., Alfinito, F., Zappia, V., and Galletti, P. (2002) Protein methylation as a marker of aspartate damage in glucose-6-phosphate dehydrogenase-deficient erythrocytes. Role of oxidative stress. Eur. J. Biochem. 269, 2032-2039
6. Watanabe, A., Takio, K., and Ihara, Y. (1999) Deamidation and isoaspartate formation in smeared tau in paired helical filaments. Unusual properties of the microtubule-binding domain of tau. J. Biol. Chem. 274, 7368-7378
7. Shimizu, T., Matsuoka, Y., and Shirasawa, T. (2005) Biological significance of isoaspartate and its repair system. Biol. Pharm. Bull. 28, 1590-1596
8. Hasegawa, M., Morishima-Kawashima, M., Takio, K., Suzuki, M., Titani, K., and Ihara, Y. (1992) Protein sequence and mass spectrometric analyses of Tau in the Alzheimer's disease brain. J. Biol. Chem. 267, 17047-17054
9. Shimizu, T., Watanabe, A., Ogawara, M., Mori, H., and Shirasawa, T. (2000) Isoaspartate formation and neurodegeneration in Alzheimer's disease. Arch. Biochem. Biophys. 381, 225-234
10. Curnis, F., Longhi, R., Crippa, L., Cattaneo, A., Dondossola, E., Bachi, A., and Corti, A. (2006) Spontaneous formation of L-isoaspartate and gain of function in fibronectin. J. Biol. Chem. 281, 36466-36476
11. Spitaleri, A., Mari, S., Curnis, F., Traversari, C., Longhi, R., Bordignon, C., Corti, A., Rizzardi, G. P., and Musco, G. (2008) Structural basis for the interaction of isoDGR with the RGD-binding site of-v-3 integrin. J. Biol. Chem. 283, 19757-19768
12. Curnis, F., Cattaneo, A., Longhi, R., Sacchi, A., Gasparri, A. M., Pastorino, F., Di Matteo, P., Traversari, C., Bachi, A., Ponzoni, M., Rizzardi, G. P., and Corti, A. (2010) Critical role of flanking residues in NGR-to-isoDGR transition and CD13/integrin receptor switching. J. Biol. Chem. 285, 9114-9123
13. Frank, A. O., Otto, E., Mas-Moruno, C., Schiller, H. B., Marinelli, L., Cosconati, S., Bochen, A., Vossmeyer, D., Zahn, G., Stragies, R., Novellino, E., and Kessler, H. (2010) Conformational control of integrin-subtype selectivity in isoDGR peptide motifs. A biological switch. Angew. Chem. Int. Ed. Engl. 49, 9278-9281
14. Corti, A., and Curnis, F. (2011) Isoaspartate-dependent molecular switches for integrin-ligand recognition. J. Cell Sci. 124, 515-522
15. Hellman, N. E., and Gitlin, J. D. (2002) Ceruloplasmin metabolism and function. Annu. Rev. Nutr. 22, 439-458
16. Vashchenko, G., and MacGillivray, R. T. (2013) Multi-copper oxidases and human iron metabolism. Nutrients 5, 2289-2313
17. Olivieri, S., Conti, A., Iannaccone, S., Cannistraci, C. V., Campanella, A., Barbariga, M., Codazzi, F., Pelizzoni, I., Magnani, G., Pesca, M., Franciotta, D., Cappa, S. F., and Alessio, M. (2011) Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention. J. Neurosci. 31, 18568-18577
18. Grimm, S., Hoehn, A., Davies, K. J., and Grune, T. (2011) Protein oxidative modifications in the ageing brain. Consequence for the onset of neurodegenerative disease. Free Radic. Res. 45, 73-88
19. Zecca, L., Youdim, M. B., Riederer, P., Connor, J. R., and Crichton, R. R. (2004) Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863-873
20. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M. (1984) Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944
21. Zhang, Y. (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9, 40
22. Hess, B., Kutzner, C., van der Spoel, D., and Lindahl, E. (2008) GROMACS 4. Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J. Chem. Theory Comput. 4, 435-447
23. de Vries, S. J., van Dijk, A. D., Krzeminski, M., van Dijk, M., Thureau, A., Hsu, V., Wassenaar, T., and Bonvin, A. M. (2007) HADDOCK versus HADDOCK. New features and performance of HADDOCK2.0 on the CAPRI targets. Proteins 69, 726-733
24. Saeed, A. I., Sharov, V., White, J., Li, J., Liang, W., Bhagabati, N., Braisted, J., Klapa, M., Currier, T., Thiagarajan, M., Sturn, A., Snuffin, M., Rezantsev, A., Popov, D., Ryltsov, A., Kostukovich, E., Borisovsky, I., Liu, Z., Vinsavich, A., Trush, V., and Quackenbush, J. (2003) TM4. A free, opensource system for microarray data management and analysis. BioTechniques 34, 374-378
25. Bento, I., Peixoto, C., Zaitsev, V. N., and Lindley, P. F. (2007) Ceruloplasmin revisited. Structural and functional roles of various metal cationbinding sites. Acta Crystallogr. D Biol. Crystallogr. 63, 240-248
26. Musci, G., Bonaccorsi di Patti, M. C., Fagiolo, U., and Calabrese, L. (1993) Age-related changes in human ceruloplasmin. Evidence for oxidative modifications. J. Biol. Chem. 268, 13388-13395
27. Kang, J. H., Kim, K. S., Choi, S. Y., Kwon, H. Y., and Won, M. H. (2001) Oxidative modification of human ceruloplasmin by peroxyl radicals. Biochim. Biophys. Acta 1568, 30-36
28. Sedlák, E., Zoldák, G., and Wittung-Stafshede, P. (2008) Role of copper in thermal stability of human ceruloplasmin. Biophys. J. 94, 1384-1391
29. Dehart, M. P., and Anderson, B. D. (2012) A mechanism-based kinetic analysis of succinimide-mediated deamidation, racemization, and covalent adduct formation in a model peptide in amorphous lyophiles. J. Pharm. Sci. 101, 3096-3109
30. Zhu, J. X., Doyle, H. A., Mamula, M. J., and Aswad, D. W. (2006) Protein repair in the brain, proteomic analysis of endogenous substrates for protein L-isoaspartyl methyltransferase in mouse brain. J. Biol. Chem. 281, 33802-33813
31. Texel, S. J., Xu, X., and Harris, Z. L. (2008) Ceruloplasmin in neurodegenerative diseases. Biochem. Soc. Trans. 36, 1277-1281
32. Ayton, S., Lei, P., Duce, J. A., Wong, B. X., Sedjahtera, A., Adlard, P. A., Bush, A. I., and Finkelstein, D. I. (2013) Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann. Neurol. 73, 554-559
33. Dawson, T. M., and Dawson, V. L. (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302, 819-822
34. Capo, C. R., Arciello, M., Squitti, R., Cassetta, E., Rossini, P. M., Calabrese, L., and Rossi, L. (2008) Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients. Biometals 21, 367-372
35. Arnal, N., Cristalli, D. O., de Alaniz, M. J., and Marra, C. A. (2010) Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives. Brain Res. 1319, 118-130
36. Brewer, G. J., Kanzer, S. H., Zimmerman, E. A., Celmins, D. F., Heckman, S. M., and Dick, R. (2010) Copper and ceruloplasmin abnormalities in Alzheimer's disease. Am. J. Alzheimers Dis. Other Demen 25, 490-497
37. Eskici, G., and Axelsen, P. H. (2012) Copper and oxidative stress in the pathogenesis of Alzheimer's disease. Biochemistry 51, 6289-6311
38. Patel, B. N., Dunn, R. J., Jeong, S. Y., Zhu, Q., Julien, J. P., and David, S. (2002) Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 22, 6578-6586
39. Luo, B. H., Carman, C. V., and Springer, T. A. (2007) Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25, 619-647
40. Grace, E. A., and Busciglio, J. (2003) Aberrant activation of focal adhesion proteins mediates fibrillar amyloid-induced neuronal dystrophy. J. Neurosci. 23, 493-502
41. Wright, S., Malinin, N. L., Powell, K. A., Yednock, T., Rydel, R. E., and Griswold-Prenner, I. (2007)-2-1 and-V-1 integrin signaling pathways mediate amyloid-induced neurotoxicity. Neurobiol. Aging 28, 226-237
42. Caltagarone, J., Jing, Z., and Bowser, R. (2007) Focal adhesions regulateA-signaling and cell death in Alzheimer's disease. Biochim. Biophys. Acta 1772, 438-445
43. Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., and Gage, F. H. (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918-934
44. Lee, K. H., Yun, S. J., Nam, K. N., Gho, Y. S., and Lee, E. H. (2007) Activation of microglial cells by ceruloplasmin. Brain Res. 1171, 1-8
45. Perez-Gracia, E., Blanco, R., Carmona, M., Carro, E., and Ferrer, I. (2009) Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer's disease. Acta Neuropathol. 118, 497-504
46. Krzyzanowska, A., and Carro, E. (2012) Pathological alteration in the choroid plexus of Alzheimer's disease. Implication for new therapy approaches. Front. Pharmacol. 3, 75
47. Serot, J. M., Zmudka, J., and Jouanny, P. (2012) A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset Alzheimer disease. J. Alzheimers Dis. 30, 17-26